search
Back to results

Diabetic Fibular Nail Study

Primary Purpose

Ankle Fractures

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Fibular intramedullary nail
Open reduction and internal fixation
Sponsored by
University of Chicago
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Ankle Fractures

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 18 or older
  • Unstable ankle fracture
  • Diagnosis of Diabetes:

    • Fasting BG > 120
    • Non-fasting BG > 200
    • HbA1c > 6.5

Exclusion Criteria:

  • Patients not meeting inclusion criteria (stable fracture patterns, non-diabetics)
  • Poly-trauma patients (multiple [>2] extremity injuries that interfere and/or limit patient mobilization
  • Open fractures
  • Delayed presentation of fracture (>4 weeks)
  • Fractures that the treating surgeon indicates requires a posterior approach to achieve stability
  • Patients with an active infection or wound at the ankle
  • Utilizing worker's compensation at the time of screening
  • Any previous ligament or fracture surgery on the index ankle
  • Inflammatory rheumatic disease or other rheumatic disease
  • Immune compromised patients (hepatitis, HIV, etc.)
  • Non-English speaking patients
  • Unwilling or unable to follow study protocol

Sites / Locations

  • University of ChicagoRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Fibular intramedullary nail

Open reduction and internal fixation (ORIF)

Arm Description

Randomized in the OR to ankle fracture repair with fibular intramedullary nail

Randomized in the OR to ankle fracture repair with ORIF

Outcomes

Primary Outcome Measures

Composite complication rate
The difference in overall composite complication rate between Fibular intramedullary fixation and ORIF

Secondary Outcome Measures

Patient reported outcome scores
Any difference in Patient reported outcomes scores (PROMIS Physical Function or Pain Interference CAT) score between Fibular Intramedullary fixation and ORIF

Full Information

First Posted
January 12, 2022
Last Updated
May 16, 2022
Sponsor
University of Chicago
search

1. Study Identification

Unique Protocol Identification Number
NCT05204485
Brief Title
Diabetic Fibular Nail Study
Official Title
Prospective, Randomized-Control Trial Comparing Intramedullary Fibular Fixation With Standard Open Reduction And Internal Fixation In Diabetic Patients With Unstable Ankle Fracture
Study Type
Interventional

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Recruiting
Study Start Date
March 7, 2022 (Actual)
Primary Completion Date
August 7, 2025 (Anticipated)
Study Completion Date
August 7, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Chicago

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Our null hypothesis is that fibular intramedullary fixation (IMFN) does not impact complication rates when compared to standard of care treatment with open reduction and internal fixation (ORIF). There are no current or past RCTs comparing these fixation techniques to one another in diabetic patients. There is good data supporting both the use of intramedullary fixation for fibular fractures alone, and in high-risk patient populations (elderly, and diabetics). However, the effectiveness of these methods with respect to each other has never been investigated. The knowledge gained will allow us to potentially influence and adapt protocols to treat this patient population. Additionally, resources available at our institution provide a supportive framework with which to maintain contact with patients after hospital discharge. These key factors will allow us to perform a robust analysis of this population, to include outcomes measures of function and complications.
Detailed Description
Our null hypothesis is that fibular intramedullary fixation (IMFN) does not impact complication rates when compared to standard of care treatment with open reduction and internal fixation (ORIF). There are no current or past RCTs comparing these fixation techniques to one another in diabetic patients. There is good data supporting both the use of intramedullary fixation for fibular fractures alone, and in high-risk patient populations (elderly, and diabetics). However, the effectiveness of these methods with respect to each other has never been investigated. The knowledge gained will allow us to potentially influence and adapt protocols to treat this patient population. Additionally, resources available at our institution provide a supportive framework with which to maintain contact with patients after hospital discharge. These key factors will allow us to perform a robust analysis of this population, to include outcomes measures of function and complications. With much of the existing literature on fibular nails being retrospective with limited focus on the diabetic population, there is no clear guidance on when the use of this device is indicated. Retrospective studies in fracture patients bring in significant bias given that a specific surgical technique may be chosen because of individual patient factors including soft tissue condition, fracture pattern and perceived level of risk. This limits our understanding of how an implant will perform across the population of interest. Our approach to randomize our patients will reduce the bias that exists in the current literature. In addition, the only prospective study that has been performed on the fibular nail was in elderly patients in which only two patients were diabetic. Given the many challenges with high rates of infection in this patient population we seek intramedullary fibular fracture fixation as a treatment that could potentially change this existing paradigm Primary Objective Compare post-operative all cause complications in diabetic patients with ankle fractures. Secondary Objective(s) Compare patient reported outcomes, range of motion, pain and radiographic outcomes in patients treated with ORIF vs. fibular intramedullary nails.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ankle Fractures

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
120 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Fibular intramedullary nail
Arm Type
Active Comparator
Arm Description
Randomized in the OR to ankle fracture repair with fibular intramedullary nail
Arm Title
Open reduction and internal fixation (ORIF)
Arm Type
Active Comparator
Arm Description
Randomized in the OR to ankle fracture repair with ORIF
Intervention Type
Procedure
Intervention Name(s)
Fibular intramedullary nail
Intervention Description
The standard manufacturers approved technique will be performed including the use of 2 distal interlocking screws and the use of a minimum of 1 fibula pro tibia fixation screw depending on the patients' anatomical characteristics.
Intervention Type
Procedure
Intervention Name(s)
Open reduction and internal fixation
Intervention Description
An open approach (direct lateral or posterolateral incision) will be carried out. The reduction will be performed using standard techniques of clamping and traction. Fixation will be performed after reduction of the fracture with a plate and screw construct. The surgeon will then proceed to perform surgical fixation of other associated fractures or ligament injuries as indicated. This will most often include open reduction and internal fixation of the medial malleolus with screws through a separate medial incision.
Primary Outcome Measure Information:
Title
Composite complication rate
Description
The difference in overall composite complication rate between Fibular intramedullary fixation and ORIF
Time Frame
1 year post-operatively
Secondary Outcome Measure Information:
Title
Patient reported outcome scores
Description
Any difference in Patient reported outcomes scores (PROMIS Physical Function or Pain Interference CAT) score between Fibular Intramedullary fixation and ORIF
Time Frame
1 year post-operatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 18 or older Unstable ankle fracture Diagnosis of Diabetes: Fasting BG > 120 Non-fasting BG > 200 HbA1c > 6.5 Exclusion Criteria: Patients not meeting inclusion criteria (stable fracture patterns, non-diabetics) Poly-trauma patients (multiple [>2] extremity injuries that interfere and/or limit patient mobilization Open fractures Delayed presentation of fracture (>4 weeks) Fractures that the treating surgeon indicates requires a posterior approach to achieve stability Patients with an active infection or wound at the ankle Utilizing worker's compensation at the time of screening Any previous ligament or fracture surgery on the index ankle Inflammatory rheumatic disease or other rheumatic disease Immune compromised patients (hepatitis, HIV, etc.) Non-English speaking patients Unwilling or unable to follow study protocol
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Justin Bell
Phone
773-834-0822
Email
jbell3@bsd.uchicago.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Kelly Hynes, MD
Phone
773-834-3531
Email
khynes@bsd.uchicago.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kelly Hynes, MD
Organizational Affiliation
University of Chicago
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Chicago
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60637
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Justin Bell, BA
Phone
773-834-0822
Email
jbell3@bsd.uchicago.edu
First Name & Middle Initial & Last Name & Degree
Kelly Hynes, MD

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
IPD will not be shared with other researchers.

Learn more about this trial

Diabetic Fibular Nail Study

We'll reach out to this number within 24 hrs